| Stage | EML | % of rev | ESCA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $62M | 100.00% | $66M | 100.00% | ESCA ×1.06 |
| Gross profit | $13M | 20.63% | $19M | 29.35% | ESCA +8.7pp |
| Operating income | $2M | 2.68% | $9M | 13.21% | ESCA +10.5pp |
| Pre-tax income | $8M | 12.14% | $9M | 13.28% | ESCA +1.1pp |
| Net income | $6M | 9.14% | $7M | 10.26% | ESCA +1.1pp |
| Stage | EML | ESCA | Gap · A − B |
|---|---|---|---|
| Revenue | $62M100.00% | $66M100.00% | ESCA ×1.06 |
| Gross profit | 20.63%$13M | 29.35%$19M | ESCA +8.7pp |
| Operating income | 2.68%$2M | 13.21%$9M | ESCA +10.5pp |
| Pre-tax income | 12.14%$8M | 13.28%$9M | ESCA +1.1pp |
| Net income |
| 9.14%$6M |
| 10.26%$7M |
| ESCA +1.1pp |
None
No disclosed counterparties: EML.